Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.
about
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor SymptomsMT1 and MT2 Melatonin Receptors: A Therapeutic PerspectiveMelatonin in Alzheimer's disease and other neurodegenerative disordersMelatonin facilitates extinction, but not acquisition or expression, of conditional cued fear in rats.The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors.Endogenous melatonin is not obligatory for the regulation of the rat sleep-wake cycle.Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.Melatonin and anesthesia: a clinical perspective.Assessment of the Potential Role of Tryptophan as the Precursor of Serotonin and Melatonin for the Aged Sleep-wake Cycle and Immune Function: Streptopelia Risoria as a Model.Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.Potency of melatonin in living beingsThe MT2 receptor stimulates axonogenesis and enhances synaptic transmission by activating Akt signaling.Convergence of melatonin and serotonin (5-HT) signaling at MT2/5-HT2C receptor heteromers.The pattern of melatonin receptor expression in the brain may influence antidepressant treatmentMelatonin Therapy in Patients with Alzheimer's Disease.Role of melatonin in Alzheimer-like neurodegeneration.Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice.Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease.Are G protein-coupled receptor heterodimers of physiological relevance?--Focus on melatonin receptors.Therapeutic application of melatonin in mild cognitive impairment.Gene and protein patterns of potential prion-related markers in the central nervous system of clinical and preclinical infected sheepMelatonin receptors, heterodimerization, signal transduction and binding sites: what's new?Melatonin in Alzheimer's diseaseMelatonin, consciousness, and traumatic stress.Microtubules modulate melatonin receptors involved in phase-shifting circadian activity rhythms: in vitro and in vivo evidence.Developmental effect of light deprivation on synaptic plasticity of rats' hippocampus: implications for melatonin.Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.Chronic ramelteon treatment in a mouse model of Alzheimer's disease.The end of a myth: cloning and characterization of the ovine melatonin MT(2) receptor.Melatonin and abeta, macular degeneration and alzheimers disease: same disease, different outcomes?Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists.The hormonal Zeitgeber melatonin: role as a circadian modulator in memory processing.Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.Protection of melatonin in experimental models of newborn hypoxic-ischemic brain injury through MT1 receptor.Monoaminergic neuropathology in Alzheimer's disease.Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.Mechanisms of Melatonin in Alleviating Alzheimer's Disease.Melatonin receptors: distribution in mammalian brain and their respective putative functions.
P2860
Q24623433-853A8F3B-25E7-485D-AB35-41271F829CC1Q28075345-439881F1-C0D9-41EA-9C82-34A4E5DF85ECQ28083929-F92FE178-3BB8-4BB6-9C97-86368A3FBF1DQ28217483-03B15437-97FB-4C7C-ABD1-8C9572C010DEQ30434239-894403FC-D223-4468-AA9D-EC6E897E8204Q33823742-E5F52AA6-7662-46CF-81AC-1853104211EEQ33897576-20E16F04-7470-4FB4-9EF5-601B45341B37Q34416921-018EEE5A-9D06-4093-B4BB-19A51ED29BE2Q34596664-B1CECF41-46B8-4A77-8F6F-1CDCBB753460Q34633689-06513DB6-5314-43EE-A359-F0858043FCD7Q34640994-0348EC36-D7A6-47AC-BB21-FDB1A01FE3BFQ34804952-AB3A601B-378F-4AC1-929D-3EA7A92728D3Q35167615-3EC108A6-C347-4318-960A-9F4F505AFF13Q35561050-F2E0FAEF-83B6-4DD5-9088-D45EC0829C66Q35945875-22C692E5-4B4B-42BD-90D9-E788AAF79003Q36335048-3C59DA22-AE07-40B7-B3E4-FC59003F04DAQ36346522-8787B1AF-4857-48D5-ABCF-E0ACC44BEF01Q36423565-C892A8AE-1B06-4EC0-91BA-B94CC21EE4C4Q36473222-A264E996-4002-4C27-B753-894D79102745Q36474528-C700D2B5-8B52-4365-A70D-607D6A047CB0Q36576496-C037B49E-DB54-461B-AB2F-9C7519C85E3BQ36716041-7154D767-2E68-4B83-A18F-444BD7498383Q36790172-7AB7046E-69B2-4DBA-8769-22F3AF72AFD0Q37091982-01EAA2B7-9DF7-46F0-8B03-673A3D2DFC36Q37138014-CF71812F-1F2A-4252-9E40-33471879FDB9Q37253704-9B26571E-AB29-4E1A-A434-EAC62E00FEEBQ37306951-546AA910-F5CD-4E25-95BC-43A4F42FF509Q37404821-1456B0CD-CFE2-43D7-A402-5A2539A56EF3Q37412437-4521E050-E7BB-4850-B7BD-30CA67C4545AQ37434418-9FB7BDDF-DD3A-459E-8DA9-D67821C725B4Q37612356-895DDF99-D4C8-466A-B390-1D5E96A20294Q37763715-9F4797BB-F924-426E-9063-C65DC8954239Q37992626-4176FEA7-39DF-4A7A-95D2-ADBB6A68561FQ38022179-1FE0015C-23E4-4DBC-8AF6-81C046D33A7AQ38243554-07DF9B14-9C32-4288-A41F-C0236E8063F2Q38630639-A2611398-F8A0-4FDC-BE70-410627BA1B5FQ38809649-B3AC18BA-88A6-411F-9097-145FC3BB93DEQ38858846-E95A8A19-CD37-47C6-8472-EB23FA047EF4Q39178920-BD563B57-6658-4F47-B74C-7938B63300A6Q39288514-00610903-196B-4C97-B5E0-7903F75DB662
P2860
Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.
@en
type
label
Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.
@en
prefLabel
Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.
@en
P2093
P2860
P1476
Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.
@en
P2093
Debora Angeloni
Egemen Savaskan
Fides Meier
Franco Fraschini
Franz Müller-Spahn
Ralf Jockers
Rivka Ravid
P2860
P356
10.1111/J.1600-079X.2004.00169.X
P577
2005-01-01T00:00:00Z